The Procter & Gamble Company (NYSE:PG) Stake Lifted by Livforsakringsbolaget Skandia Omsesidigt

Livforsakringsbolaget Skandia Omsesidigt increased its position in shares of The Procter & Gamble Company (NYSE:PGFree Report) by 49.9% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 80,820 shares of the company’s stock after purchasing an additional 26,910 shares during the period. Procter & Gamble accounts for about 0.7% of Livforsakringsbolaget Skandia Omsesidigt’s investment portfolio, making the stock its 25th largest holding. Livforsakringsbolaget Skandia Omsesidigt’s holdings in Procter & Gamble were worth $13,996,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently added to or reduced their stakes in PG. Itau Unibanco Holding S.A. acquired a new position in shares of Procter & Gamble in the 2nd quarter worth approximately $28,000. Fairway Wealth LLC acquired a new position in Procter & Gamble in the second quarter worth approximately $29,000. Ruedi Wealth Management Inc. increased its holdings in shares of Procter & Gamble by 64.7% in the first quarter. Ruedi Wealth Management Inc. now owns 196 shares of the company’s stock valued at $32,000 after buying an additional 77 shares in the last quarter. POM Investment Strategies LLC acquired a new stake in shares of Procter & Gamble during the 2nd quarter valued at $34,000. Finally, Transcendent Capital Group LLC acquired a new position in shares of Procter & Gamble in the 4th quarter worth $31,000. 65.77% of the stock is currently owned by institutional investors and hedge funds.

Procter & Gamble Price Performance

Shares of NYSE:PG opened at $171.09 on Friday. The company has a market cap of $403.80 billion, a price-to-earnings ratio of 27.96, a PEG ratio of 3.67 and a beta of 0.41. The business has a 50 day moving average price of $171.48 and a 200 day moving average price of $166.74. The company has a quick ratio of 0.53, a current ratio of 0.73 and a debt-to-equity ratio of 0.51. The Procter & Gamble Company has a twelve month low of $141.66 and a twelve month high of $177.94.

Procter & Gamble (NYSE:PGGet Free Report) last posted its quarterly earnings results on Tuesday, July 30th. The company reported $1.40 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.37 by $0.03. Procter & Gamble had a net margin of 17.71% and a return on equity of 33.46%. The company had revenue of $20.53 billion for the quarter, compared to analyst estimates of $20.69 billion. During the same period last year, the business posted $1.37 EPS. The business’s quarterly revenue was down .1% on a year-over-year basis. Research analysts predict that The Procter & Gamble Company will post 6.97 earnings per share for the current year.

Procter & Gamble Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Friday, October 18th will be paid a $1.0065 dividend. This represents a $4.03 dividend on an annualized basis and a dividend yield of 2.35%. The ex-dividend date of this dividend is Friday, October 18th. Procter & Gamble’s dividend payout ratio is 65.69%.

Analyst Upgrades and Downgrades

A number of equities analysts recently weighed in on the company. Deutsche Bank Aktiengesellschaft increased their price target on Procter & Gamble from $171.00 to $176.00 and gave the company a “buy” rating in a research report on Wednesday, July 17th. Stifel Nicolaus lifted their target price on shares of Procter & Gamble from $157.00 to $161.00 and gave the stock a “hold” rating in a research report on Monday, July 22nd. Jefferies Financial Group downgraded shares of Procter & Gamble from a “buy” rating to a “hold” rating and reduced their price target for the company from $182.00 to $175.00 in a research report on Wednesday, July 24th. JPMorgan Chase & Co. lifted their price objective on shares of Procter & Gamble from $179.00 to $186.00 and gave the stock an “overweight” rating in a research report on Thursday, September 19th. Finally, Citigroup increased their target price on Procter & Gamble from $177.00 to $190.00 and gave the company a “buy” rating in a report on Wednesday, July 10th. Ten investment analysts have rated the stock with a hold rating, twelve have assigned a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $175.05.

Check Out Our Latest Analysis on PG

Insider Transactions at Procter & Gamble

In other Procter & Gamble news, insider Balaji Purushothaman sold 8,842 shares of the firm’s stock in a transaction dated Thursday, August 1st. The shares were sold at an average price of $164.90, for a total transaction of $1,458,045.80. Following the completion of the transaction, the insider now owns 11,537 shares in the company, valued at $1,902,451.30. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In other Procter & Gamble news, insider Balaji Purushothaman sold 8,842 shares of the company’s stock in a transaction dated Thursday, August 1st. The shares were sold at an average price of $164.90, for a total transaction of $1,458,045.80. Following the sale, the insider now directly owns 11,537 shares of the company’s stock, valued at approximately $1,902,451.30. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Jon R. Moeller sold 7,007 shares of the stock in a transaction that occurred on Wednesday, October 2nd. The stock was sold at an average price of $171.65, for a total value of $1,202,751.55. Following the sale, the chief executive officer now owns 269,172 shares in the company, valued at approximately $46,203,373.80. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 383,194 shares of company stock valued at $65,140,718. Company insiders own 0.17% of the company’s stock.

About Procter & Gamble

(Free Report)

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.

See Also

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.